ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,816Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 761

$531K Total Retail Price of All Prescriptions

Rank: 105 out of 761

699 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 7,091 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 383 302 1 1
OMEPRAZOLE 334 245 2 4
SIMVASTATIN 292 226 3 2
FUROSEMIDE 288 255 4 7
LOVASTATIN 279 196 5 17
LEVOTHYROXINE SODIUM 259 238 6 3
CARVEDILOL 256 193 7 26
WARFARIN SODIUM 244 201 8 9
METFORMIN HCL 242 147 9 10
HYDROCODONE-ACETAMINOPHEN 225 153 S3 10 5
AMLODIPINE BESYLATE 208 183 11 6
MELOXICAM 172 106 12 61
CYCLOBENZAPRINE HCL 160 41 R 13 51
TAMSULOSIN HCL 157 122 14 27
ATORVASTATIN CALCIUM 156 128 15 12
ZOLPIDEM TARTRATE 148 95 16 22
METOPROLOL TARTRATE 145 111 17 14
GABAPENTIN 134 81 18 15
CITALOPRAM HBR 134 86 18 19
ALLOPURINOL 132 124 20 28
POTASSIUM CHLORIDE 132 117 20 18
HYDROCHLOROTHIAZIDE 126 104 22 11
PREDNISONE 118 81 23 30
TRAZODONE HCL 116 65 24 23
MORPHINE SULFATE ER 110 40 S2 25 38
ATENOLOL 95 90 26 8
OXYCODONE HCL 89 34 S2 27 24
SERTRALINE HCL 87 81 28 25
PREMARIN 86 65 R 29 88
PRAVASTATIN SODIUM 84 77 30 20
SPIRIVA 82 52 31 56
FENOFIBRATE 81 29 32 91
GLIMEPIRIDE 79 39 33 48
DONEPEZIL HCL 78 76 34 33
TRAMADOL HCL 77 48 35 34
LOSARTAN POTASSIUM 74 70 36 13
CIPROFLOXACIN HCL 68 47 37 63
ESCITALOPRAM OXALATE 63 44 38 102
ESTRADIOL 60 24 R 39 80
POLYETHYLENE GLYCOL 3350 59 47 40 62
DIGOXIN 57 53 41 43
PROAIR HFA 55 27 42 32
LYRICA 55 18 42 134
OXYCODONE-ACETAMINOPHEN 55 24 S2 42 49
AZITHROMYCIN 54 40 45 70
METOPROLOL SUCCINATE 54 46 45 16
ADVAIR DISKUS 50 36 47 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.